ReviewCurrent gene therapy2009

Uncertainty in the translation of preclinical experiments to clinical trials. Why do most phase III clinical trials fail?

Pedro R Lowenstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.